MyFinsight
Home
Blog
About
Back
Income Statement
Vistagen Therapeutics, Inc. (VTGN)
Vistagen Therapeutics, Inc. (VTGN)
source: myfinsight.com
Comprehensive loss
-$13,035K
(13.67%↑ Y/Y)
Net loss
-$13,030K
(13.68%↑ Y/Y)
Unrealized loss on
marketable securities
-$5K
(-25.00%↓ Y/Y)
Loss before income
taxes
-$13,030K
(13.68%↑ Y/Y)
Interest income, net
$319K
(-55.13%↓ Y/Y)
Loss from operations
-$13,348K
(15.54%↑ Y/Y)
Total revenues
$1,476K
(504.92%↑ Y/Y)
Other income
-$1K
(50.00%↑ Y/Y)
Total operating
expenses
$14,824K
(-7.63%↓ Y/Y)
Research and development
$10,906K
(-6.61%↓ Y/Y)
General and
administrative
$3,918K
(-10.34%↓ Y/Y)
Back